Every guide, in one place.

GLP-1 medications cause constipation in up to 30% of users — here are the fiber supplements that actually help, ranked by tolerability and evidence.

When solid food feels impossible, liquid protein keeps your muscles intact and your energy stable. Here are the 8 best options for GLP-1 users.

Reduced food intake on GLP-1 medications means reduced iron intake — and the symptoms of deficiency look a lot like medication side effects.

When appetite is suppressed and nothing sounds good, these 25 snacks deliver strategic protein in small, manageable portions.

Magnesium deficiency worsens constipation, muscle cramps, sleep problems, and anxiety — all things GLP-1 medications already amplify. Here is how to fix it.

Rapid fat loss releases stored vitamin D, creating a paradox that can leave you deficient when you need it most — here is what to do about it.

A dietitian-informed roundup of meal replacement shakes that deliver balanced nutrition when full meals feel impossible on GLP-1 medications.

Rapid weight loss on GLP-1 medications can leave skin loose and joints aching — here is what collagen supplements can (and cannot) do about it.

Reduced food intake means reduced nutrient intake — here is when a multivitamin makes sense on GLP-1 therapy and which ones are worth your money.

Nausea, reduced intake, and GI side effects make electrolyte depletion a real risk on GLP-1 medications — here is what to drink and when.

When your appetite is suppressed, every calorie needs to count — these protein bars deliver 15g+ protein under 250 calories without wrecking your stomach.

GLP-1 medications may impair B12 absorption, and if you are also on metformin, the risk doubles. Here is what to test, what to take, and when to worry.

Bone broth delivers gentle protein, collagen, and electrolytes in a sippable format — making it one of the most practical foods for GLP-1 nausea days.

When you are eating 800-1,200 calories a day, micronutrient gaps are real. We looked at whether greens powders actually fill them.

GLP-1 medications change your gut motility and microbiome. The right probiotic can ease GI side effects — but not all strains are equal.

Wegovy and Zepbound are now approved for adolescents 12 and older. Here's what the clinical trials showed, what parents should consider, and how pediatric treatment works in practice.

Midlife weight loss has different rules. Muscle matters more, hormones are shifting, and your bones care about how fast you lose. Here's what patients over 40 need to know about GLP-1 therapy.

GLP-1 medications can significantly reduce binge eating episodes — but they don't treat the psychological roots of BED. Here's what the evidence supports and what it doesn't.

Loose skin after weight loss on GLP-1 medications is common and mostly depends on how much you lose, how fast, and factors you can't control. Here's what works, what doesn't, and what it costs.

Weight loss from GLP-1 medications can dramatically reduce joint stress — but joint pain is also a reported side effect. Here's how to sort out which is which.

Diabetes remission is possible for some patients on GLP-1 medications — but it depends on timing, biology, and what 'reversal' actually means. Here's what the trials show.

GLP-1 medications slow gastric emptying, which can change how your other drugs absorb. Here's the complete guide to interactions — what's safe, what needs monitoring, and what to time carefully.

GLP-1 medications protect kidneys in some patients and stress them in others. The difference usually comes down to hydration and monitoring. Here's what the data shows and what to watch.

GLP-1 medications don't just help with weight — they meaningfully improve your lipid panel. Here's what the data shows for LDL, triglycerides, HDL, and cardiovascular risk.

GLP-1 medications change the way your gut works — literally. Here's what's happening inside, which side effects are normal, and how to eat your way through the adjustment period.

PlushCare is in-network with more insurers than any other major GLP-1 telehealth program. We signed up, ran the intake, and tracked the real costs. Here's whether the insurance advantage is worth it.

Reports of depression, suicidal ideation, and mood changes on GLP-1s made headlines in 2023-2024. Here's what the FDA found, what the trials show, and what to watch for.

Every GLP-1 carries a black-box warning about thyroid C-cell tumors. It's the most alarming thing on the label — and the most misunderstood. Here's what the data actually shows and who needs to worry.

The oral version of Wegovy was approved in 2026, giving patients a needle-free path to the same molecule. Here's how it compares to the injection, what the pill actually requires, and who it's best for.

Rapid weight loss on GLP-1s can change how your face looks — sometimes dramatically. Here's why it happens, what's normal vs concerning, and what dermatologists and plastic surgeons are actually recommending.

Medicare has historically excluded anti-obesity medications, but the landscape is shifting. Here's the current state of coverage, the new pathways opening up, and what Medicare beneficiaries can actually do today.

Ro is one of the biggest names in telehealth. Their GLP-1 weight loss program is fast and slick — but the clinical model and pricing have trade-offs worth understanding before you sign up.

Exercise on a GLP-1 isn't optional — it's the difference between losing weight and getting healthier. Here's how to structure cardio, strength training, and recovery when your appetite is suppressed and your body is changing fast.

Boehringer Ingelheim's survodutide takes a different approach — activating glucagon alongside GLP-1. The result is strong weight loss plus a unique effect on liver fat that could make it the first drug to treat MASH. Here's where it stands.

Appetite suppression is the point of GLP-1 therapy — but it makes hitting protein targets genuinely hard. Here's a practical meal prep system designed for patients who aren't hungry but still need to eat right.

A head-to-head comparison of three popular telehealth GLP-1 programs across pricing, clinical depth, medications offered, and real user experience.

Constipation is one of the most common GLP-1 side effects. Here's why delayed gastric emptying causes it and evidence-based strategies to manage it.

Rapid weight loss on GLP-1s increases gallstone risk. Here's why it happens, warning signs to watch for, and what you can do to reduce your risk.

An independent review of Calibrate's year-long metabolic reset program — pricing, what's included, clinical approach, and whether it's worth $1,500+.

GLP-1 drugs can improve sleep apnea and disrupt sleep patterns. Here's what the research shows and practical tips for better sleep on Ozempic, Wegovy, or Zepbound.

An independent review of Found's telehealth GLP-1 program — pricing, provider quality, medication options, and whether it's worth it vs. competitors.

How long before conception should you stop Ozempic, Wegovy, or Zepbound? Washout timelines, fertility effects, and what the prescribing information says.

Amgen's MariTide is a once-monthly GLP-1/GIP antibody-peptide conjugate in Phase 3 trials. How it works, early results, and what it means for the GLP-1 market.

Protein is the most important macronutrient on a GLP-1. Here's exactly how much you need, why it matters for muscle preservation, and practical strategies to hit your target.

An independent review of Sequence's physician-led GLP-1 program — pricing, clinical model, insurance support, and how it compares to Calibrate and Found.

The two FDA-approved obesity drugs go head to head — efficacy, side effects, cost, insurance coverage, and who each one is actually right for.

GLP-1 medications must be stopped before pregnancy — but they may actually improve fertility first. Here's the evidence on both sides, the recommended timelines, and why your prescriber needs to be in the loop.

These are the two dominant GLP-1 molecules in 2026. SURMOUNT-5 compared them directly. Here's what the trial showed, what it didn't, and how to decide between them for your situation.

Realistic weight loss expectations on Ozempic, Wegovy, and Zepbound — month by month from your first injection through year two.

For many GLP-1 patients, the most life-changing effect isn't weight loss — it's the silence. The constant mental chatter about food stops. Here's the neuroscience of food noise, how GLP-1s turn it down, and why it matters more than the scale.

The FDA has resolved the semaglutide and tirzepatide shortages, and the rules around compounded GLP-1s have changed dramatically. Here's the current landscape — what's still available, what's not, and the risks.

The SELECT trial was the first to prove that a GLP-1 reduces heart attacks and strokes in patients with obesity. Here's what the data shows, who benefits most, and how this changes the insurance and prescribing landscape.

Most people regain a meaningful share of lost weight within a year of stopping a GLP-1. Here's what the data actually shows, why it happens, and the four strategies prescribers are using to make discontinuation work.

The list price is $935/month, but almost nobody pays that. Here's what Ozempic actually costs without insurance — and 6 ways to pay less.

Hair shedding is one of the most upsetting GLP-1 side effects — and one of the most misunderstood. Here's why it happens (the answer is mostly not what you think), how long it lasts, and the interventions that have evidence behind them.

Eli Lilly and Novo Nordisk now both sell their GLP-1 medications directly to self-pay patients. We compared real prices, eligibility rules, and the experience end-to-end. Here's which one wins for your situation.

Roughly 25–40% of weight lost on a GLP-1 is lean mass — much of it muscle. That number can be cut substantially with the right protein, training, and dosing approach. Here's the protocol that's working in 2026.

Mounjaro and Zepbound are the exact same molecule (tirzepatide) made by the same company. So why two names, two prices, and two sets of insurance rules? Here's what's actually going on — and how to use it to your advantage.

The week-1 food playbook for GLP-1 users when nothing sounds good. Practical moves that keep nausea down and protein up.

A non-peptide pill, 15% weight loss, and potentially much cheaper to manufacture. Why Lilly's orforglipron could restructure the GLP-1 market.

When appetite drops, protein becomes critical. These are the best options to protect muscle on Ozempic and Wegovy.

No labs, no long intake, shipped in days. Here's what $199/mo gets you — and what it doesn't.

24% weight loss in Phase 2, three-hormone mechanism, and on track for FDA filing in 2026-2027. Here's what retatrutide actually is and why it matters.

Physician-led, the thorough intake, and real behavioral coaching. Here's what $59/mo + meds actually buys you in 2026.

Flat $99/mo with real insurance navigation and a dietitian. Here's what actually arrived in the mail, what we got wrong, and who it's not for.

How tirzepatide works, why its results are dramatically better than semaglutide, and whether the price makes it the right pick for you.

We signed up for every major telehealth program, tracked the real costs, and ranked them by who you actually are — not by who pays us the most.

Same molecule, two brands, wildly different rules. Here's what actually separates them and what it means for cost, coverage, and who should take which.

The pill finally exists. Here's how it compares on results, price, and who should switch — and who definitely shouldn't.